Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Cidofovir for Recurrent Respiratory Papillomatosis
NCT00205374Phase 4Completed
- Sponsor
- University of Wisconsin–Madison
- Start
- Nov 1999
- Primary completion
- Dec 2009
- Modality
- Small Molecules
01
Overview
A Phase 4 trial of cidofovir in recurrent respiratory papillomatosis (RRP), sponsored by University of Wisconsin–Madison. Started Nov 1999; status: completed.
02
Drugs
cidofovir
03
Conditions
recurrent respiratory papillomatosis (RRP)
Beyond the preview
Go deeper on NCT00205374.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00205374.